Results 291 to 300 of about 254,961 (327)

Substantia Nigra Iron Deposition in Lewy Body Disease: A Magnetic Resonance Imaging and Neuropathology Study

Movement Disorders, EarlyView.
Abstract Objective To compare iron deposition in the substantia nigra (SN) as measured with quantitative susceptibility mapping (QSM) on antemortem magnetic resonance imaging (MRI) between individuals with and without Lewy‐related pathology at autopsy. Methods We performed a retrospective cohort study including 54 participants who underwent autopsy and
Patricia Diaz‐Galvan, Scott A. Przybelski, Timothy G. Lesnick, Melissa E. Murray, Aivi Nguyen, Ross R. Reichard, Dennis W. Dickson, Daisuke Ono, Matthew L. Senjem, Christopher G. Schwarz, Jeffrey Gunter, Val Lowe, Leah K. Forsberg, Julie A. Fields, Rodolfo Savica, Jonathan Graff‐Radford, Vijay K. Ramanan, David Jones, Hugo Botha, Erik K. St. Louis, David Knopman, Gregory S. Day, Neill Graff‐Radford, Walter Kremers, Ronald C. Petersen, Clifford R. Jack Jr, Tanis J. Ferman, Bradley F. Boeve, Kejal Kantarci   +28 more
wiley   +1 more source

Attention/Working Memory and Executive Function in Parkinson's Disease: Review, Critique, and Recommendations

Movement Disorders, EarlyView.
Abstract Background Cognitive impairment in Parkinson's disease (PD) is a well‐established non‐motor complication that significantly affects the quality of life and well‐being of both patients and care partners. To optimally detect mild cognitive impairment or dementia, extensive neuropsychological assessment is essential.
Roberta Biundo, Ondrej Bezdicek, Davide Maria Cammisuli, Brenna Cholerton, John C. Dalrymple‐Alford, Nicola Edelstyn, Eleonora Fiorenzato, Erin Holker, Saul Martinez‐Horta, Alice Martini, Gabriella Santangelo, Barbara Segura, Chiara Siri, Alexander Tröster, Tiago A. Mestre, Álvaro Sánchez Ferro, Michelle Hyczy de Siqueira Tosin, Matej Skorvanek, Daniel Weintraub, Gert J. Geurtsen, and the members of the MDS Clinical Outcome Assessment Scientific Evaluation Committee   +20 more
wiley   +1 more source

Elevated Levels of Extracellular Vesicle‐Associated TAOK1 in Plasma: A Diagnostic Marker for Cognitive Decline in Parkinson's Disease Dementia and Alzheimer's Disease

Movement Disorders, EarlyView.
Pin‐Jui Kung, Yi‐Tzang Tsai, Rwei‐Ling Yu, Hsiang‐Hsuan Lin‐Wang, Ming‐Che Kuo, Chia‐Ching Wu, Chien‐Tai Hong, Koji Ueda, Shau‐Ping Lin, Ruey‐Meei Wu   +9 more
wiley   +1 more source

Assessment of neuropsychological testing [PDF]

Neurology, 1997
To the Editor: I wanted to respond to certain aspects of the recent report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology published in the August 1996 issue of Neurology . For the most part, this special article provides helpful and accurate guidance to neurologists about our field.
Kenneth M. Adams, Bryon Rourke, Linas A. Bieliauskas, Eileen Fennell, Thomas A. Hammeke   +4 more
  +22 more sources

Some of the next articles are maybe not open access.

Related searches:

Neuropsychological Testing

Alzheimer Disease & Associated Disorders, 2005
Neuropsychological testing is important for the diagnosis and follow-up of dementia; it can also help provide consultation on patient care. However, lengthy testing is costly and can be stressful to the subjects. Tests developed for members of the majority culture often are inappropriate for ethnic minorities, especially those who speak a different ...
Jennifer J. Manly, Evelyn L. Teng
openaire   +2 more sources

Psychometrics of a neuropsychological test battery

Journal of Clinical Psychology, 1978
Compared factor analysis (linear) and hierarchical cluster analysis (nonlinear) of a neuropsychological battery of tests, including the Wechsler Adult Intelligence Scale, the Wechsler Memory Scale, the Graham-Kendall Memory for Designs Test, and the Bender Visual Motor Gestalt Designs Test. The results were discussed within the framework of descriptive
Robert Zager, Jack Arbit
openaire   +3 more sources

The Cerebellum in Neuropsychological Testing

2008
As we have seen, the cerebellum plays a role in a variety of cognitive processes. These domains include attention and executive functioning, speech and language, visuospatial functioning, and learning and memory, as discussed in Chapter 5 (Schmahmann, 2004). These functions are all routinely assessed in a standard neuropsychological assessment.
Deborah Ely Budding, Leonard F. Koziol
openaire   +2 more sources

Executive Dysfunction and Neuropsychological Testing

2008
Publisher Summary A dysexecutive syndrome is expected in brain disorders that affect any of the different parts of the frontostriatal system. Executive functions should thus be systematically assessed in patients with cognitive, behavioral, or motor disturbances.
Richard Levy, Katia Andrade, Bruno Dubois   +2 more
openaire   +3 more sources

The SKT Neuropsychological Test Battery

Journal of Geriatric Psychiatry and Neurology, 1992
The SKT is a brief neuropsychological test battery that includes nine performance subtests that define two independent factors of memory and attention deficit. It requires no more than 15 minutes to administer and has five parallel forms. Developed in Germany, it has been used successfully to document improved performance of patients in trials of ...
John E. Overall, Ralf Schaltenbrand
openaire   +3 more sources

Psychological and Neuropsychological Testing

2021
In this chapter, we review the topic of neuropsychological evaluation, its indications, components, limitations, and interpretation.
openaire   +2 more sources